Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells

American Journal of Physiology - Renal Physiology

Volumn 298, Issue 5, 2010, Pages

  Lee, Yu Jin ^a   Han, Ho Jae ^a  

^a Chonnam National University   (South Korea)

Author keywords

Agonist; Epithelial mesenchymal transition; Glucose uptake; Peroxisome proliferator activated receptor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ASCORBIC ACID; BETA CATENIN; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROGEN PEROXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SODIUM GLUCOSE COTRANSPORTER; SODIUM PROTON EXCHANGE PROTEIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; TROGLITAZONE; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIUM CELL; GLUCOSE TRANSPORT; KIDNEY PROXIMAL TUBULE; MALE; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT;

EID: 77951528072     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00475.2009     Document Type: Article

References (63)

1. Aiello A, Pandini G, Frasca F, Conte E, Murabito A, Sacco A, Genua M, Vigneri R, Belfiore A. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells. Endocrinology 147: 4463-4475, 2006. (Pubitemid 44268398)
2. Amemiya M, Loffing J, Lötscher M, Kaissling B, Alpern RJ, Moe OW. Expression of NHE-3 in the apical membrane of rat renal proximal tubule and thick ascending limb. Kidney Int 48: 1206-1215, 1995.
3. Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 168: 29-33, 2005. (Pubitemid 40111054)
4. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, García De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
5. Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando) 22: 1-5, 2008. (Pubitemid 350131582)
6. Benkirane K, Amiri F, Diep QN, El Mabrouk M, Schiffrin EL. PPAR-γ inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. Am J Physiol Heart Circ Physiol 290: H390-H397, 2006.
7. + exchanger isoform of renal brush border. Am J Physiol Renal Fluid Electrolyte Physiol 265: F736-F742, 1993.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
9. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, Thomas MC, Cooper ME, Kantharidis P. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 17: 2484-2494, 2006. (Pubitemid 44300964)
10. Cao LQ, Chen XL, Wang Q, Huang XH, Zhen MC, Zhang LJ, Li W, Bi J. Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells. Acta Pharmacol Sin 28: 879-887, 2007. (Pubitemid 46817439)
11. Cheng HC, Ho TC, Chen SL, Lai HY, Hong KF, Tsao YP. Troglitazone suppresses transforming growth factor β-mediated fibrogenesis in retinal pigment epithelial cells. Mol Vis 14: 95-104, 2008.
12. Chung SD, Alavi N, Livingston D, Hiller S, Taub M. Characterization of primary rabbit kidney cultures that express proximal tubule functions in a hormonally defined medium. J Cell Biol 95: 118-126, 1982. (Pubitemid 13197081)
13. Chana RS, Lewington AJ, Brunskill NJ. Differential effects of peroxisome proliferator activated receptor-γ ligands in proximal tubular. Kidney Int 65: 2091-12090, 2004.
14. Crljen V, Sabolić I, Susac J, Appenroth D, Herak-Kramberger CM, Ljubojević M, Anzai N, Antolović R, Burckhardt G, Fleck C, Sabolić I. Immunocytochemical characterization of the incubated rat renal cortical slices. Pflügers Arch 450: 269-279, 2005. (Pubitemid 40966581)
15. Dellow WJ, Chambers ST, Lever M, Lunt H, Robson RA. Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia. Diabetes Res Clin Pract 43: 91-99, 1999. (Pubitemid 29155653)
16. Docherty NG, O'Sullivan OE, Healy DA, Murphy M, O'neill AJ, Fitzpatrick JM, Watson RW. TGF-β1-induced EMT can occur independently of its proapoptotic effects and is aided by EGF receptor activation. Am J Physiol Renal Physiol 290: F1202-F1212, 2006.
17. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM, Birembaut P. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112: 4615-4625, 1999. (Pubitemid 30034810)
18. 2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-κB-p300 pathway independent of peroxisome proliferator-activated receptor γ. J Immunol 173: 5196-5208, 2004.
19. Goetze S, Eilers F, Bungenstock A, Kintscher U, Stawowy P, Blaschke F, Graf K, Law RE, Fleck E, Gräfe M. PPAR activators inhibit endothelial cell migration by targeting Akt. Biochem Biophys Res Commun 293: 1431-1437, 2002. (Pubitemid 34681037)
20. Groves CE, Suhre WB, Cherrington NJ, Wright SH. Sex differences in the mRNA, protein, and functional expression of organic anion transporter (Oat) 1, Oat3, and organic cation transporter (Oct) 2 in rabbit renal proximal tubules. J Pharmacol Exp Ther 316: 743-752, 2005.
21. Guan J. Peroxisome proliferator-activated receptor family and its relationship to renal complication of the metabolic syndrome. J Am Soc Nephrol 15: 2801-2815, 2004.
22. Guan Y, Zhang Y, Breyer MD. The role of PPARs in the transcriptional control of cellular processes. Drug News Perspect 15: 147-154, 2002. (Pubitemid 34601271)
23. Guarino M. Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol Histopathol 10: 171-184, 1995.
24. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62: 1613-1618, 2002.
25. Hamilton KL, Butt AG. The molecular basis of renal tubular transport disorders. Comp Biochem Physiol A Mol Integr Physiol 126: 305-321, 2000. (Pubitemid 30645598)
26. Han HJ, Choi HJ, Park SH. High glucose inhibits glucose uptake in renal proximal tubule cells by oxidative stress and protein kinase C. Kidney Int 57: 918-926, 2000.
27. +/glucose cotransporter activity in renal proximal tubule cells. Am J Physiol Renal Physiol 288: F988-F996, 2005.
28. Harris RC, Brenner BM, Seifter JL. Sodium-hydrogen exchange and glucose transport in renal microvillus membrane vesicles from rats with diabetes mellitus. J Clin Invest 77: 724-733, 1986.
29. Holian J, Qi W, Kelly DJ, Zhang Y, Mreich E, Pollock CA, Chen XM. Role of Kruppel-like factor 6 in transforming growth factor-β1-induced epithelial-mesenchymal transition of proximal tubule cells. Am J Physiol Renal Physiol 295: F1388-F1396, 2008.
30. Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI, Hong SP, Hong SD. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells. J Exp Clin Cancer Res 28: 28, 2009.
31. Iglesias P, Díez JJ. Peroxisome proliferator-activated receptor γ agonists in renal disease. Eur J Endocrinol 154: 613-621, 2006.
32. Kanie N, Matsumoto T, Kobayashi T, Kamata K. Relationship between peroxisome proliferator-activated receptors (PPAR α and PPAR γ) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats. Br J Pharmacol 140: 23-32, 2003.
33. Kattla JJ, Carew RM, Heljic M, Godson C, Brazil DP. Protein kinase B/Akt activity is involved in renal TGF-β1-driven epithelial-mesenchymal transition in vitro and in vivo. Am J Physiol Renal Physiol 295: F215-F225, 2008.
34. Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, Doi T, Kohno N, Yorioka N. PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β. Lab Invest 89: 47-58, 2009.
35. Kim K, Lu Z, Hay ED. Direct evidence for a role of β-catenin/LEF-1 signalling pathway in induction of EMT. Cell Biol Int 26: 463-476, 2002.
36. Lee CS, Kwon YW, Yang HM, Kim SH, Kim TY, Hur J, Park KW, Cho HJ, Kang HJ, Park YB, Kim HS. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3β followed by inhibition of MMP-9. Arterioscler Thromb Vasc Biol 29: 472-479, 2009.
37. Lee HB, Yu MR, Song JS, Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 65: 1170-1179, 2004.
38. Lee JM, Dedhar S, Kallouri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981, 2006.
39. Lee KS, Park JH, Lee S, Lim HJ, Jang Y, Park HY. Troglitazone inhibits endothelial cell proliferation through suppression of casein kinase 2 activity. Biochem Biophys Res Commun 346: 83-88, 2006.
40. Lee YJ, Heo JS, Suh HN, Lee MY, Han HJ. Interleukin-6 stimulates α-MG uptake in renal proximal tubule cells: involvement of STAT3, PI3K/Akt, MAPKs, and NF-κB. Am J Physiol Renal Physiol 293: F1036-F1046, 2007.
41. +/glucose cotransporters in renal proximal tubule cells. Kidney Int Suppl 106: S27-S35, 2007.
42. Lee YJ, Suh HN, Han HJ. Effect of BSA-induced ER stress on SGLT protein expression levels and α-MG uptake in renal proximal tubule cells. Am J Physiol Renal Physiol 296: F1405-F1416, 2009.
43. Li Y, Wen X, Spataro BC, Hu K, Dai C, Liu Y. Hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-γ agonists. J Am Soc Nephrol 7: 54-65, 2006.
44. Liu J, Farmer SR. Regulating the balance between peroxisome proliferator-activated receptor γ and β-catenin signaling during adipogenesis. A glycogen synthase kinase 3β phosphorylation-defective mutant of β-catenin inhibits expression of a subset of adipogenic genes. J Biol Chem 279: 45020-45027, 2004.
45. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12, 2004.
46. Maeda M, Johnson KR, Wheelock MJ. Cadherin switching: essential for behavioural but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 118: 873-887, 2005.
47. Muller T, Bain G, Wang X, Papkoff J. Regulation of epithelial cell migration and tumor formation by β-catenin signalling. Exp Cell Res 280: 119-133, 2002.
48. Panchapakesan U, Sumual S, Pollock CA, Chen X. PPARγ agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. Am J Physiol Renal Physiol 289: F1153-F1158, 2005.
49. Park CW, Kim HW, Ko SH, Chung HW, Lim SW, Yang CW, Chang YS, Sugawara A, Guan Y, Breyer MD. Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha. Diabetes 55: 885-893, 2006.
50. 2 signal cascade in renal proximal tubule cells. Kidney Int 61: 913-925, 2002.
51. Rahmoune H, Thompson PW, Ward JM, Smith CD, Hong G, Brown J. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes 54: 3427-3434, 2005.
52. Sakhrani LM, Badie-Dezfooly B, Trizna W, Mikhail N, Lowe AG, Taub M, Fine LG. Transport and metabolism of glucose by renal proximal tubular cells in primary culture. Am J Physiol Renal Fluid Electrolyte Physiol 246: F757-F764, 1984.
53. Sartippour MR, Renier G. Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose: role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression. Arterioscler Thromb Vasc Biol 20: 104-110, 2000.
54. Simonson MS. Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int 71: 846-854, 2007.
55. Sommer M, Wolf G. Rosiglitazone increases PPARγ in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Am J Nephrol 27: 425-434, 2007.
56. Stemmer V, de Craene B, Berx G, Behrens J. Snail promotes Wnt target gene expression and interacts with β-catenin. Oncogene 27: 5075-5080, 2008.
57. Toblli JE, Ferrini MG, Cao G, Vernet D, Angerosa M, Gonzalez-Cadavid NF. Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus. Nephrol Dial Transplant 24: 2384-2391, 2009.
58. Wang F, Gao L, Gong B, Hu J, Li M, Guan Q, Zhao J. Tissue-specific expression of PPAR mRNAs in diabetic rats and divergent effects of cilostazol. Can J Physiol Pharmacol 86: 465-471, 2008.
59. Wang W, Liu F, Chen N. Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists attenuate the profibrotic response induced by TGF-β1 in renal interstitial fibroblasts. Mediators Inflamm: 62641, 2007.
60. Wei JL, Ma CY, Zhang YD, Li Y. Synergistic effects of pravastatin and pioglitazone in renal tubular epithelial cells induced by transforming growth factor-β1. Cell Biol Int 31: 451-458, 2007.
61. Xu J, Lamouille S, Derynck R. TGF-β-induced epithelial to mesenchymal transition. Cell Res 19: 156-172, 2009.
62. Yu MA, Shin KS, Kim JH, Kim YI, Chung SS, Park SH, Kim YL, Kang DH. HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol 20: 567-581, 2009.
63. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6: 931-940, 2004.